Insight on What Matters - So You Can Transform Your Business.
Careful examination of your company from an external perspective and addressing potential buyers’ concerns in advance will not only increase the likelihood of receiving the price that was agreed to in the term sheet, but will also make the deal move faster and improve the chance of a successful outcome.
Here are four tips for preparing your company for the due diligence process.
Perhaps you’ve heard the saying that technology companies are generally bought, not sold. That’s true. The largest, most active buyers—companies like IBM, Google, Oracle, and Microsoft—are continually seeking out and evaluating emerging technology companies to expand their portfolios. This has two important implications for the selling company.
ShareVault was updated on Sunday, May 10th, adding the important enhancements.
How many people does it take to run a successful biotech company? The traditional model of the biotech company in the glass-fronted building with a sparkling fountain out front and employing a hundred or more scientists working on a long pipeline of assets may be on the way out.
Below are several areas of your company that will be scrutinized by a buyer and can potentially kill your deal.
Technology transfer is the process of getting these ideas out of the lab and classroom and into the market. Technology transfer offices facilitate the transfer of these discoveries to companies that can in turn develop them into products and services that benefit society.
When evaluating virtual data rooms for your application, look for the following characteristics and features.
Are your employees downloading unauthorized apps on personal devices or using Dropbox, Google Docs, or other SaaS platforms that can lead to document leakages, lost business and financial penalties?
As a result, emerging growth biotechnology companies are increasingly pursuing alternative financing vehicles, including equity crowdfunding, to advance their drug development programs.
Blog